Variables | Total | CLEC-2 ≤ 166.3 | CLEC-2 > 166.3 | p value |
---|---|---|---|---|
Age (years) | 0.298 | |||
≤ 65 | 309 (71.9) | 247 (70.8) | 62 (76.5) | |
> 65 | 121 (28.1) | 102 (29.2) | 19 (23.5) | |
Gender | 0.432 | |||
Male | 245 (57.0) | 202 (57.9) | 43 (53.1) | |
Female | 185 (43.0) | 147 (42.1) | 38 (46.9) | |
BMI (kg/m2) | 23.4 ± 3.2 | 23.9 ± 3.2 | 23.3 ± 3.2 | 0.166 |
Current smoker | 0.906 | |||
Yes | 183 (42.6) | 149 (42.0) | 34 (42.0) | |
No | 247 (57.4) | 200 (58.0) | 47 (58.0) | |
Drinker | 0.401 | |||
Yes | 139 (32.3) | 116 (33.2) | 23 (28.4) | |
No | 291 (67.7) | 233 (66.8) | 58 (71.6) | |
WBC (×109/L) | 7.09 ± 2.44 | 7.35 ± 3.16 | 7.03 ± 2.25 | 0.393 |
Hemoglobin (g/L) | 132.9 ± 23.4 | 129.4 ± 25.2 | 133.7 ± 23.0 | 0.141 |
Platelet count (×109/L) | 270.0 ± 87.8 | 265.6 ± 82.8 | 286.9 ± 105.7 | 0.093 |
Creatinine (umol/L) | 81.1 ± 18.6 | 83.0 ± 28.4 | 80.6 ± 15.4 | 0.467 |
CEA (ng/ml) | 4.37 (2.03–11.31) | 3.82 (1.94–13.70) | 4.67 (2.12–10.67) | 0.768 |
Tumor size (cm) | 0.260 | |||
< 5.0 | 278 (64.7) | 230 (65.9) | 48 (59.3) | |
≥ 5.0 | 152 (35.3) | 119 (34.1) | 33 (40.7) | |
Tumor location | 0.687 | |||
Proximal | 157 (36.5) | 129 (37.0) | 28 (34.6) | |
Distal | 273 (63.5) | 220 (63.0) | 53 (65.4) | |
Histological type | 0.383 | |||
Non-mucinous | 359 (83.5) | 294 (84.2) | 65 (80.2) | |
Mucinous | 71 (28.6) | 55 (15.8) | 16 (19.8) | |
Histological grade | 0.835 | |||
Well/Moderately differentiated | 359 (83.5) | 292 (83.7) | 67 (82.7) | |
Poorly differentiated | 71 (28.6) | 57 (16.3) | 14 (17.3) | |
Lymphatic invasion | 0.285 | |||
Absent | 331 (77.0) | 265 (75.9) | 66 (81.5) | |
Present | 99 (23.0) | 84 (24.1) | 15 (18.5) | |
Perineural invasion | 0.545 | |||
Absent | 365 (84.9) | 298 (85.4) | 67 (82.7) | |
Present | 65 (15.1) | 51 (14.6) | 14 (17.3) | |
T classification | 0.693 | |||
T1 + T2 | 63 (14.7) | 50 (14.3) | 13 (16.0) | |
T3 + T4 | 367 (85.3) | 299 (85.7) | 68 (84.0) | |
Lymph node metastasis | 0.665 | |||
Absence | 267 (62.1) | 215 (61.6) | 52 (64.2) | |
Presence | 163 (37.9) | 134 (38.4) | 29 (35.8) | |
Distant metastasis | 0.707 | |||
Absence | 382 (88.8) | 311 (89.1) | 71 (87.7) | |
Presence | 48 (11.2) | 38 (10.9) | 10 (12.3) | |
Stage | 0.392 | |||
I-II | 258 (60.0) | 206 (59.0) | 52 (64.2) | |
III-I | 172 (40.0) | 143 (41.0) | 29 (35.8) | |
MSI status | < 0.001*** | |||
MSS | 366 (85.1) | 318 (91.1) | 48 (59.3) | |
MSI-H | 64 (14.9) | 31 (8.9) | 33 (40.7) |